These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25158985)

  • 1. Meta-analysis of factor V Leiden and prothrombin G20210A polymorphism in migraine.
    Lippi G; Mattiuzzi C; Cervellin G
    Blood Coagul Fibrinolysis; 2015 Jan; 26(1):7-12. PubMed ID: 25158985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.
    Bagheri M; Rad IA; Nanbakhsh F
    Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.
    Mazoyer E; Ripoll L; Gueguen R; Tiret L; Collet JP; dit Sollier CB; Roussi J; Drouet L;
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction.
    Forte GI; Vaccarino L; Palmeri M; Branzi A; Caldarera CM; Scola L; Caruso C; Licastro F; Lio D
    Biogerontology; 2011 Oct; 12(5):485-90. PubMed ID: 21918818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
    Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY
    Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale.
    Favaretto E; Sartori M; Conti E; Legnani C; Palareti G
    Thromb Res; 2012 Nov; 130(5):720-4. PubMed ID: 22909823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.
    Hatzaki A; Anagnostopoulou E; Metaxa-Mariatou V; Melissinos C; Philalithis P; Iliadis K; Kontaxis A; Liberatos K; Pangratis N; Nasioulas G
    Int Angiol; 2003 Mar; 22(1):79-82. PubMed ID: 12771861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.
    Almawi WY; Keleshian SH; Borgi L; Fawaz NA; Abboud N; Mtiraoui N; Mahjoub T
    J Thromb Thrombolysis; 2005 Dec; 20(3):163-8. PubMed ID: 16261289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behçet's disease.
    Ateş A; Düzgün N; Ulu A; Tiryaki AO; Akar N
    Pathophysiol Haemost Thromb; 2003; 33(3):157-63. PubMed ID: 15170396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombotic polymorphisms in patients with Raynaud's phenomenon and migraine.
    Takáts AT; Shemirani AH; Zsóri KS; András C; Csiki Z
    Acta Physiol Hung; 2012 Dec; 99(4):430-5. PubMed ID: 23238545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited prothrombotic risk factors in children with stroke, transient ischemic attack, or migraine.
    Herak DC; Antolic MR; Krleza JL; Pavic M; Dodig S; Duranovic V; Brkic AB; Zadro R
    Pediatrics; 2009 Apr; 123(4):e653-60. PubMed ID: 19336355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.